GlucoTrack, Inc.
GCTK
$0.85
-$0.07-7.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.86M | 1.14M | 1.65M | 1.63M | 2.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.49M | 4.31M | 4.80M | 3.50M | 3.85M |
| Operating Income | -3.49M | -4.31M | -4.80M | -3.50M | -3.85M |
| Income Before Tax | -3.63M | -4.17M | -4.76M | -6.83M | -10.09M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.63M | -4.17M | -4.76M | -6.83M | -10.09M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.63M | -4.17M | -4.76M | -6.83M | -10.09M |
| EBIT | -3.49M | -4.31M | -4.80M | -3.50M | -3.85M |
| EBITDA | -3.47M | -4.30M | -4.79M | -3.49M | -3.84M |
| EPS Basic | -3.97 | -4.64 | -9.62 | -40.35 | -- |
| Normalized Basic EPS | -2.48 | -2.90 | -6.01 | -25.22 | -- |
| EPS Diluted | -3.97 | -4.64 | -9.62 | -40.35 | -- |
| Normalized Diluted EPS | -2.48 | -2.90 | -6.01 | -25.22 | -- |
| Average Basic Shares Outstanding | 912.90K | 899.40K | 494.50K | 169.30K | -- |
| Average Diluted Shares Outstanding | 912.90K | 899.40K | 494.50K | 169.30K | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |